MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2024 All rights reserved. Tickeron Inc.

CYCN Cyclerion Therapeutics Forecast, Technical & Fundamental Analysis

a developer of pharmaceutical products for serious and orphan diseases

Industry Biotechnology
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
Ad is loading...
A.I. Advisor
published Earnings

CYCN is expected to report earnings to rise 75.00% to -28 cents per share on August 08

Cyclerion Therapeutics CYCN Stock Earnings Reports
Q2'23
Est.
$-0.28
Q1'23
Beat
by $0.14
Q4'22
Beat
by $0.12
Q3'22
Beat
by $5.96
Q2'22
Missed
by $0.01
The last earnings report on May 11 showed earnings per share of -15 cents, beating the estimate of -30 cents. With 184.73K shares outstanding, the current market capitalization sits at 8.89M.
A.I. Advisor
published General Information

General Information

a developer of pharmaceutical products for serious and orphan diseases

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
245 First Street
Phone
+1 857 327-8778
Employees
1
Web
https://www.cyclerion.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME31.261.82
+6.18%
GameStop Corp
TSLA479.8616.84
+3.64%
Tesla
AAPL253.482.44
+0.97%
Apple
BTC.X106140.600000110.890625
+0.10%
Bitcoin cryptocurrency
SPY604.29-2.50
-0.41%
SPDR® S&P 500® ETF Trust

CYCN and Stocks

Correlation & Price change

A.I.dvisor tells us that CYCN and GDTC have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CYCN and GDTC's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CYCN
1D Price
Change %
CYCN100%
-7.08%
GDTC - CYCN
31%
Poorly correlated
-3.02%
HRTX - CYCN
31%
Poorly correlated
-1.79%
FRES - CYCN
31%
Poorly correlated
-10.54%
BLUE - CYCN
30%
Poorly correlated
+14.85%
ENTO - CYCN
25%
Poorly correlated
-3.95%
More